Use of Intermittent Preventive Treatment of malaria, 2+ doses of SP/Fansidar (% of pregnant women)

Save the current configuration of this report including all selections, filters, and sorting.
Description to be displayed for the saved view.
Fields
Share

Percentage of women with a live birth in the recent years preceding the survey who received 2+ doses of sulfadoxine-pyrimethamine (SP/Fansidar), at least one during an antenatal care visit. Intermittent Preventive Treatment (IPT) is preventive treatment with SP/Fansidar during an antenatal care (ANC) visit treatment with a dose of sulfadoxine-pyrimethamine (SP/Fansidar) to pregnant women at each scheduled antenatal visit after the first trimester, but not more frequently than once a month.......Source: UNICEF Childinfo, Multiple Indicator Cluster Surveys, Demographic and Health Surveys
Source: The World Bank: Health Nutrition and Population Statistics    # of Reporting Countries: 48
Frequency: Annual    Earliest: 2003-12     Latest: 2016-12

2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12
1) Angola
17.5
2) Benin
22.8
3) Burkina Faso
10.6
45.7
4) Burundi
0.3
0.1
5) Cameroon
25.6
6) Central African Republic
38.2
7) Chad
21.9
16.4
8) Comoros
27.8
9) Congo
22.2
10) DR Congo
20.8
14.3
11) Equatorial Guinea
24.3
12) Gabon
2.6
13) Gambia
66.2
62.3
14) Ghana
67.1
67.5
15) Guinea Bissau
14.2
16) Guinea
17.8
17) Heavily indebted poor countries (HIPC)
28.69
29.5
18) Ivory Coast
17.6
19) Kenya
16.9
34.7
20) Liberia
49.6
47.6
21) Madagascar
19.5
18.2
22.3
22) Malawi
60.1
53.2
59.1
63.4
23) Mali
51
19.9
24) Mauritania
18.9
25) Mozambique
18.6
26) Namibia
4.9
27) Niger
34.8
28) Nigeria
13.2
19.5
14.6
37.2
29) Senegal
38.6
41.3
40
30) Sierra Leone
41.4
45.1
31) South Sudan
19
25.8
32) Sub-Saharan Africa (all income levels)
24.08
33) Sub-Saharan Africa (developing only)
24.08
34) Sudan
2.3
35) Swaziland
1.4
36) Tanzania
26.3
31.8
34.6
37) Togo
50.2
43.6
38) Uganda
24.5
45.2
39) Zambia
69.4
69.8
72.7
40) Zimbabwe
7.3
12.9
CSV